Birmingham Patient Has Received Iron Strong Award
The O'Neal Comprehensive Cancer Center honored Rebecca Hall for her participation in a recent clinical trial.
Updated on Oct. 2, 2026 in Cancer
Rebecca Hall, a patient at the University of Alabama at Birmingham, received the Iron Strong Award for her resilience during cancer treatment. Hall successfully navigated a clinical trial after her cancer returned in 2018.
Why it matters
The award recognizes Hall's participation in a specialized clinical trial for HER2-positive breast cancer that offered a life-saving alternative when her prognosis was extremely limited.
Hall underwent a clinical trial involving a surgical device placed in her head to measure medication levels, with recent scans now showing no evidence of active disease. This progress follows her previous 2015 remission period.
The players
Rebecca Hall
She is a Hoover resident who successfully completed a clinical trial for HER2-positive breast cancer.
O'Neal Comprehensive Cancer Center
Based at the University of Alabama at Birmingham, this facility provides specialized cancer treatments and research.
The details
After a 2013 breast cancer diagnosis and double mastectomy, Hall experienced a recurrence in the membranes surrounding her brain in 2018. She enrolled in a trial to receive medications directed toward her brain membranes, a procedure that has resulted in lingering hearing loss and reduced hand motor function.
Timeline
Hall received her initial cancer diagnosis in 2013.
Her cancer went into remission in 2015.
The cancer returned to her brain membranes in 2018.
The article regarding the award was published in October 2026.
Deeper Dive
The case follows the treatment protocols established by the O'Neal Comprehensive Cancer Center for recurrent breast cancer cases. This work represents a shift toward localized drug delivery for cancers that have spread to the membranes around the brain.
Patients dealing with brain-membrane cancer recurrence may find new hope in specialized clinical trials that deliver medication directly to the site of the disease. Individuals should discuss potential trial eligibility with their oncology teams at research-focused centers.
The takeaway
Advancements in clinical trials can offer life-extending options even for patients with severe prognosis diagnoses. Hall's story underscores the importance of participating in medical research to test potentially breakthrough therapies.
Further reading
For more information on current treatment developments, visit Cancer.
Source note: This article includes information reported by WBMA.
